Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
about
Single nucleotide polymorphisms in the apolipoprotein B and low density lipoprotein receptor genes affect response to antihypertensive treatmentAngiotensin receptor gene polymorphisms and 2-year change in hyperintense lesion volume in men.PharmGKB summary: very important pharmacogene information for angiotensin-converting enzyme.Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle.Do genetic variants of the Renin-Angiotensin system predict blood pressure response to Renin-Angiotensin system-blocking drugs?: a systematic review of pharmacogenomics in the Renin-Angiotensin systemA case for pharmacogenomics in management of cardiac arrhythmias.Polymorphism in angiotensin II receptor genes and hypertension.Genomic variation and neurohormonal intervention in heart failure.Impact of GPCRs in clinical medicine: monogenic diseases, genetic variants and drug targetsGenomic association analysis identifies multiple loci influencing antihypertensive response to an angiotensin II receptor blocker.Pharmacogenetics of cardiovascular drug therapy.Genetic polymorphisms related to the renin-angiotensin-aldosterone system and response to antihypertensive drugs.Pharmacogenomic approaches to study the effects of antihypertensive drugs.Gene-environment interactions of selected pharmacogenes in arterial hypertension.Pharmacogenomics of heart failure: a systematic review.The Pharmacogenomic and Metabolomic Predictors of ACE Inhibitor and Angiotensin II Receptor Blocker Effectiveness and Safety.Impact of renin-angiotensin-aldosterone system genes on the treatment response of patients with hypertension and metabolic syndrome.Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).Beta1-adrenergic receptor gene polymorphisms and response to beta1-adrenergic receptor blockade in patients with essential hypertension.Renin-angiotensin system gene polymorphisms: relationship with blood pressure and microalbuminuria in telmisartan-treated hypertensive patients.Renin-angiotensin system and alpha-adducin gene polymorphisms and their relation to responses to antihypertensive drugs: results from the GENRES study.Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan.Conceptual basis and methodology of the SOPHIA study.Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study.
P2860
Q24803618-11AB821A-79CC-4334-8D0A-123811DF39EDQ33940391-6223BADC-7695-4809-8282-012FA76AADA8Q34994915-F56C9DFA-7F4F-4992-B582-CC00E09A2273Q35109802-9697B4B6-DC79-4FD1-AB91-0380224A23D6Q35230775-CB7858AB-CC3B-4FD7-A2CA-C93078869AAAQ35914690-F640325A-21B9-4B23-95CE-F03277586A8BQ36003958-26B4D09B-B287-4C51-BDE0-77D97B09AB36Q36170188-85C2681B-6F30-43B6-B21B-F9D7DDB03B49Q36316001-9AD8FA3B-E6B9-43BE-925F-5A924D54BD99Q36489410-24BF2146-DF4B-4343-8B00-CA1D8DCE9FC4Q37430401-AD528284-54D2-4C7C-987E-57C833BBE1C9Q37681549-9CE7961B-E155-4F2B-94B7-5E8B1737F923Q38022144-B226EF26-7823-42F6-ACAB-D932CF0D7DB2Q38066959-6EF52408-A32C-443F-AB14-AA3C31EA45AFQ38998634-622E77C3-72F7-4DA8-997D-68217DD90025Q39456476-967B7420-92D9-4501-9B21-AC2622FA83D9Q40133099-731422E2-A1AB-42EC-91A8-4330CD3AB7AAQ44930351-6CC2BFF9-3F28-4085-9F9C-0D214910E880Q44966749-4DDF319F-30B8-4943-AED7-4FA095780E5DQ45125171-DEB121AC-1D91-4743-93BB-195EA4F75E2CQ46213467-5E23457B-9C44-4064-90E3-39CE7DAB52C1Q46507308-11DAE02D-EC17-4AE2-952C-9D6C7B59698AQ46885454-9AB96A47-69A4-487D-870A-52A5F093BD6BQ51158549-87EFF05A-15F9-4E73-815A-85C6EAAAD11BQ55070146-03A78E38-1CA9-4719-B21E-717C9268AC69
P2860
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Angiotensin converting enzyme ...... ment in hypertensive patients.
@en
type
label
Angiotensin converting enzyme ...... ment in hypertensive patients.
@en
prefLabel
Angiotensin converting enzyme ...... ment in hypertensive patients.
@en
P2093
P1476
Angiotensin converting enzyme ...... ment in hypertensive patients.
@en
P2093
J Karlsson
K Malmqvist
Swedish Irbesartan Left Ventri ...... ersus Atenolol (SILVHIA) Trial
P304
P356
10.1097/00004872-200110000-00012
P577
2001-10-01T00:00:00Z